AstraZeneca India aims to accelerate innovation and clinical trials, enhancing access to life-saving medicines for patients.

ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...

The company that operates the Y-12 National Security Complex in Oak Ridge will have a new leader on July 1. Todd Ailes will take over as Consolidated Nuclear Security's new president and chief ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Spotlighting Innovation in Novel Targeting Formats & Payloads to Enhance Delivery, Overcome Payload Resistance and Expand Therapeutic Reach Novel conjugates have become one of the most competitive and ...

The Council today adopted a set of restrictive measures to combat Russia’s war of aggression against Ukraine, its hybrid activities and its systematic disregard for international law, including human ...

Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Pete Rathburn is a copy editor and fact-checker ...

Iksuda Therapeutics develops next-generation antibody-drug conjugate (ADC) therapies to target cancers that are difficult to treat, or resistant to current treatments, without damaging healthy cells.